These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 8321867)

  • 1. Vitiligo: where do we stand?
    Ortonne JP; Bose SK
    Pigment Cell Res; 1993 Mar; 6(2):61-72. PubMed ID: 8321867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?
    Gauthier Y; Cario Andre M; Taïeb A
    Pigment Cell Res; 2003 Aug; 16(4):322-32. PubMed ID: 12859615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanocyte destruction and repigmentation in vitiligo: a model for nerve cell damage and regrowth.
    Yu HS
    J Biomed Sci; 2002; 9(6 Pt 2):564-73. PubMed ID: 12432222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanocytes are not absent in lesional skin of long duration vitiligo.
    Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU
    J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.
    Le Poole IC; van den Wijngaard RM; Westerhof W; Das PK
    Am J Pathol; 1996 Apr; 148(4):1219-28. PubMed ID: 8644862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the etiopathomechanism of vitiligo: a convergence theory.
    Le Poole IC; Das PK; van den Wijngaard RM; Bos JD; Westerhof W
    Exp Dermatol; 1993 Aug; 2(4):145-53. PubMed ID: 8162332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitiligo.
    Kovacs SO
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):647-66; quiz 667-8. PubMed ID: 9591808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
    Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
    J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.
    Cario-André M; Pain C; Gauthier Y; Taïeb A
    Pigment Cell Res; 2007 Oct; 20(5):385-93. PubMed ID: 17850512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into immune mechanisms of vitiligo.
    Boniface K; Taïeb A; Seneschal J
    G Ital Dermatol Venereol; 2016 Feb; 151(1):44-54. PubMed ID: 26512930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines: the yin and yang of vitiligo pathogenesis.
    Singh M; Kotnis A; Jadeja SD; Mondal A; Mansuri MS; Begum R
    Expert Rev Clin Immunol; 2019 Feb; 15(2):177-188. PubMed ID: 30462555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes.
    Shajil EM; Chatterjee S; Agrawal D; Bagchi T; Begum R
    Indian J Exp Biol; 2006 Jul; 44(7):526-39. PubMed ID: 16872041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for an autoimmune pathogenesis of vitiligo.
    Ongenae K; Van Geel N; Naeyaert JM
    Pigment Cell Res; 2003 Apr; 16(2):90-100. PubMed ID: 12622785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
    van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM
    J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal reconstructs in vitiligo: an extrinsic factor is needed to trigger the disease.
    Bessou S; Gauthier Y; Surlève-Bazeille JE; Pain C; Taïeb A
    Br J Dermatol; 1997 Dec; 137(6):890-7. PubMed ID: 9470904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathogenesis of vitiligo.
    Sandoval-Cruz M; García-Carrasco M; Sánchez-Porras R; Mendoza-Pinto C; Jiménez-Hernández M; Munguía-Realpozo P; Ruiz-Argüelles A
    Autoimmun Rev; 2011 Oct; 10(12):762-5. PubMed ID: 21334464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitiligo: current medical and scientific understanding.
    Boissy RE; Nordlund JJ
    G Ital Dermatol Venereol; 2011 Feb; 146(1):69-75. PubMed ID: 21317859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization.
    Birlea SA; Costin GE; Roop DR; Norris DA
    Med Res Rev; 2017 Jul; 37(4):907-935. PubMed ID: 28029168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetics of generalized vitiligo.
    Spritz RA
    Curr Dir Autoimmun; 2008; 10():244-57. PubMed ID: 18460890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.
    Boniface K; Seneschal J; Picardo M; Taïeb A
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):52-67. PubMed ID: 28685247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.